|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...7172737475767778798081...110111» |
- Enrollment change, Metastases: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy (clinicaltrials.gov) - Feb 25, 2014
P=N/A, N=249, Active, not recruiting, Sponsor: Gynecologic Oncology Group
N=200 --> 249
- Enrollment closed, Metastases: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy (clinicaltrials.gov) - Feb 25, 2014
P=N/A, N=249, Active, not recruiting, Sponsor: Gynecologic Oncology Group
N=200 --> 249 Recruiting --> Active, not recruiting
- ||||||| Avastin (bevacizumab) / Roche
Trial completion: OCEANS: A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma (clinicaltrials.gov) - Feb 25, 2014
P3, N=484, Completed, Sponsor: Genentech
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial initiation date: Human Papillomavirus and Rate of Pregnancy Achieved Via Medically Assisted Procreation (clinicaltrials.gov) - Feb 24, 2014
P=N/A, N=700, Not yet recruiting, Sponsor: Centre Hospitalier Universitaire de Nīmes
Active, not recruiting --> Completed Initiation date: Jan 2014 --> Jun 2014
- Enrollment closed: Gene Expression in Cumulus Cells to Predict Pregnancy (clinicaltrials.gov) - Feb 24, 2014
P=N/A, N=200, Active, not recruiting, Sponsor: Gema Diagnostics
Initiation date: Jan 2014 --> Jun 2014 Recruiting --> Active, not recruiting
- Trial completion: Project WORTH: The Multimedia HIV/STI Prevention for Drug-Involved Female Offenders (clinicaltrials.gov) - Feb 24, 2014
P2, N=306, Completed, Sponsor: Columbia University
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Enrollment open: PACT: Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders (clinicaltrials.gov) - Feb 24, 2014
P=N/A, N=480, Recruiting, Sponsor: Columbia University
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||| Trial completion: Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote Areas (clinicaltrials.gov) - Feb 24, 2014
P0, N=5079, Completed, Sponsor: Barretos Cancer Hospital
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||| lifastuzumab vedotin (DNIB0600A) / Roche
Trial initiation date: A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC) (clinicaltrials.gov) - Feb 23, 2014
P2, N=92, Recruiting, Sponsor: Genentech
Active, not recruiting --> Completed Initiation date: Nov 2013 --> Feb 2014
- DS-7423 / Daiichi Sankyo
Enrollment change, Metastases: Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors (clinicaltrials.gov) - Feb 23, 2014
P1, N=42, Completed, Sponsor: Daiichi Sankyo Inc.
Initiation date: Nov 2013 --> Feb 2014 N=66 --> 42
- |||| Orgovyx (relugolix) / Intas, Gedeon Richter, Takeda, ASKA Pharma, Sumitomo Pharma, Pfizer
Trial completion: Efficacy and Safety of TAK-385 in the Treatment of Endometriosis (clinicaltrials.gov) - Feb 23, 2014
P2, N=487, Completed, Sponsor: Takeda
N=66 --> 42 Recruiting --> Completed
- | DS-7423 / Daiichi Sankyo
Trial completion, Metastases: Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors (clinicaltrials.gov) - Feb 23, 2014
P1, N=42, Completed, Sponsor: Daiichi Sankyo Inc.
Recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Effects of Hormonal Infertility Treatment on Cognition in Pre-Menopausal Women (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=80, Completed, Sponsor: National Institute on Aging (NIA)
Active, not recruiting --> Completed No longer recruiting --> Completed
- ||||||| tranexamic acid oral / Generic mfg.
Trial completion: Safety Study of XP12B in Women With Menorrhagia (clinicaltrials.gov) - Feb 22, 2014
P3, N=784, Completed, Sponsor: Ferring Pharmaceuticals
No longer recruiting --> Completed Active, not recruiting --> Completed
- |||| Orilissa (elagolix) / AbbVie
Trial completion: Endometriosis Trial: Study of NBI-56418 in Endometriosis (clinicaltrials.gov) - Feb 22, 2014
P2, N=76, Completed, Sponsor: Abbott
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Trial completion: Colpopexy and Urinary Reduction Efforts (CARE) Protocol (clinicaltrials.gov) - Feb 22, 2014
P3, N=322, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
No longer recruiting --> Completed No longer recruiting --> Completed
- | azithromycin / Generic mfg.
Trial completion: Azithromycin/Bicillin Syphilis (clinicaltrials.gov) - Feb 22, 2014
P3, N=593, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Avastin (bevacizumab) / Roche
Trial completion, Metastases: Bevacizumab and Erlotinib Study in Advanced Ovarian Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=40, Completed, Sponsor: University of Arizona
Active, not recruiting --> Completed Active, not recruiting --> Completed
- famciclovir / Generic mfg.
Trial completion: A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding (clinicaltrials.gov) - Feb 22, 2014
P4, N=0, Completed, Sponsor: Novartis
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Trial completion, MRI: Computed Tomotherapy (CT) and Magnetic Resonance Imaging (MRI) Fusion on Radiation Treatment Planning for Patients With Cancer of the Cervix (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=10, Completed, Sponsor: AHS Cancer Control Alberta
No longer recruiting --> Completed Recruiting --> Completed
- | Trial completion, Metastases: Comparison of Tomotherapy Versus Intensity-modulated Step-and-shoot and Conventional Radiation Treatment Plans for Patients With Locally-advanced Squamous Cell Carcinoma of the Cervix (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=10, Completed, Sponsor: AHS Cancer Control Alberta
Recruiting --> Completed Recruiting --> Completed
- | Xcytrin (motexafin gadolinum) / AbbVie
Trial completion, Metastases: Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer (clinicaltrials.gov) - Feb 22, 2014
P1, N=25, Completed, Sponsor: Pharmacyclics
Recruiting --> Completed No longer recruiting --> Completed
- | Trial completion, Surgery, Tumor cell, Biopsy: EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=60, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed Recruiting --> Completed
- ||||||| Telcyta (canfosfamide) / MabVax
Trial completion, Combination therapy: TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer (clinicaltrials.gov) - Feb 22, 2014
P3, N=244, Completed, Sponsor: Telik
Recruiting --> Completed Active, not recruiting --> Completed
- | Erbitux (cetuximab) / Eli Lilly, EMD Serono
Trial completion, Combination therapy, IO biomarker, Metastases: Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women (clinicaltrials.gov) - Feb 22, 2014
P1, N=30, Completed, Sponsor: UNC Lineberger Comprehensive Cancer Center
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Tirazone (tirapazamine) / Teclison, SRI International
Trial completion, Combination therapy, Metastases: Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer (clinicaltrials.gov) - Feb 22, 2014
P1, N=22, Completed, Sponsor: Peter MacCallum Cancer Centre, Australia
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Biomarker, Trial completion, BRCA Biomarker, Surgery: Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=40, Completed, Sponsor: University of Arizona
Active, not recruiting --> Completed Recruiting --> Completed
- | ispinesib (SB-715992) / Cytokinetics
Trial completion: Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=35, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Completed No longer recruiting --> Completed
- | oxaliplatin / Generic mfg.
Trial completion: Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment (clinicaltrials.gov) - Feb 22, 2014
P2, N=180, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Metastases: Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors (clinicaltrials.gov) - Feb 22, 2014
P1, N=30, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | pemetrexed / Generic mfg.
Trial completion: Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | docetaxel / Generic mfg.
Trial completion: Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Biopsy: Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap Smears (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=1070, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Recruiting --> Completed
- | Trial completion, Metastases: Healing Touch and Relaxation Therapies in Cervical Cancer Patients (clinicaltrials.gov) - Feb 22, 2014
P2, N=60, Completed, Sponsor: National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting --> Completed No longer recruiting --> Completed
- | Trial completion: Efficacy of (clinicaltrials.gov) - Feb 22, 2014
P2, N=60, Completed, Sponsor:
No longer recruiting --> Completed Recruiting --> Completed
- | Triapine (3-AP) / Vion, Northwestern University
Trial completion, Combination therapy: 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=48, Completed, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed Active, not recruiting --> Completed
- | acyclovir / Generic mfg.
Trial completion: A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes (clinicaltrials.gov) - Feb 22, 2014
P3, N=3682, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Albert Einstein College of Medicine of Yeshiva University
Active, not recruiting --> Completed No longer recruiting --> Completed
- | oxaliplatin / Generic mfg.
Trial completion: Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: Gynecologic Oncology Group
No longer recruiting --> Completed No longer recruiting --> Completed
- | docetaxel / Generic mfg.
Trial completion, Combination therapy: Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=48, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed Recruiting --> Completed
- | erlotinib / Generic mfg.
Biomarker, Trial completion, Metastases: Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck (clinicaltrials.gov) - Feb 22, 2014
P1/2, N=80, Completed, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed Active, not recruiting --> Completed
- | Erbitux (cetuximab) / Eli Lilly, EMD Serono
Trial completion, IO biomarker, Metastases: Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=39, Completed, Sponsor: ImClone LLC
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | bortezomib / Generic mfg., carboplatin / Generic mfg.
Trial completion: PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer (clinicaltrials.gov) - Feb 22, 2014
P1, N=21, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed No longer recruiting --> Completed
- | abagovomab (ACA 125) / Menarini
Trial completion: Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer (clinicaltrials.gov) - Feb 22, 2014
P1, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Telcyta (canfosfamide) / MabVax
Trial completion: TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer (clinicaltrials.gov) - Feb 22, 2014
P3, N=440, Completed, Sponsor: Telik
Active, not recruiting --> Completed No longer recruiting --> Completed
- | topotecan / Generic mfg.
Trial completion, Metastases: Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (clinicaltrials.gov) - Feb 22, 2014
P1, N=20, Completed, Sponsor: Beth Israel Deaconess Medical Center
No longer recruiting --> Completed Recruiting --> Completed
- | Trial completion: Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia (clinicaltrials.gov) - Feb 22, 2014
P2, N=84, Completed, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed No longer recruiting --> Completed
- | Trial completion: Vaginal Changes and Sexual Function in Patients With Cervical Cancer (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=0, Completed, Sponsor: Gynecologic Oncology Group
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Telcyta (canfosfamide) / MabVax
Trial completion, Combination therapy: TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer (clinicaltrials.gov) - Feb 22, 2014
P1/2, N=28, Completed, Sponsor: Telik
Active, not recruiting --> Completed No longer recruiting --> Completed